Fish Vaccine Market could be worth 355.88 million by 2030,says Premium Market Insights

The fish vaccine market size was valued at US$ 355.88 Mn in 2022 and is expected to reach US$ 617.38 Mn by 2030; it is estimated to record a CAGR of 7.1% from 2022 to 2030.Fish Vaccine Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Vaccine Type (Inactivated Vaccines, Live Vaccines, Subunit Vaccines, Recombinant Vector Vaccine, and Others), Application (Bacterial, Viral, and Parasitic), Route of Administration (Injected, Immersion, and Oral), Species (Salmon, Trout, Tilapia, and Others), and Geography (North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America)

Get PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/TIP00076896?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: Fish Vaccine Market:
Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.
Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India

Zoetis Inc
Merck & Co Inc
Hipra SA
Phibro Animal Health Corp
Vaxxinova International BV
Kyoto Biken Laboratories
Elanco Animal Health Inc
Nisseiken Co., Ltd.
KBNP Inc
Choong Ang Vaccine Laboratories Co., Ltd.
INDIAN IMMUNOLOGICALS LTD
Bottom of Form

Chapter Details of Fish Vaccine Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Fish Vaccine Market Landscape
Part 04: Fish Vaccine Market Sizing
Part 05: Fish Vaccine Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/TIP00076896?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sushant More
SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.